Back to Results

Nivolumab with standard of care chemotherapy for the first line treatment of peripheral T cell lymphoma

Study category: Cancer

Is this Study for You?

Let's Get Started!




I/II - A combination of phases: (1) Research Studies that focus on the safety of a drug. The goal is to determine the drug's most frequent and serious adverse events and, often, how the drug is broken down and excreted by the body. These studies usually involve a small number of participants; and (2) Research Studies that gather preliminary data on whether a drug works in people who have a certain condition/disease (that is, the drug's effectiveness). For example, participants receiving the drug may be compared to similar participants receiving a different treatment, usually an inactive substance (called a placebo) or a different drug. Safety continues to be evaluated, and short-term adverse events are studied.

Type of Study



City of Hope Cancer Center
Lone Tree Medical Center
Thomas Jefferson University Hospital Cancer Center
University of Colorado Hospital

Principal Investigator
Brad Haverkos,  MD

Brad Haverkos, MD

Study ID

Protocol Number: 18-0708 NCT03586999


Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers